High-grade ureteroscopic biopsy is associated with advanced pathology of upper-tract urothelial carcinoma tumors at definitive surgical resection

Journal of Endourology

Volumn 26, Issue 4, 2012, Pages 398-402

  Clements, Thomas ^a   Messer, Jamie C ^a   Terrell, John D ^b   Herman, Michael P ^c   Ng, Casey K ^c   Scherr, Douglas S ^c   Scoll, Benjamin ^d   Boorjian, Stephen A ^d   Uzzo, Robert G ^d   Wille, Mark ^e   Eggener, Scott E ^e   Lucas, Steven M ^b   Lotan, Yair ^b   Shariat, Shahrokh F ^c   Raman, Jay D ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c WEILL CORNELL MEDICAL CENTER   (United States)

^d FOX CHASE CANCER CENTER   (United States)

^e UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED CANCER; ARTICLE; BIOPSY; CANCER GRADING; CANCER INVASION; CLINICAL FEATURE; COHORT ANALYSIS; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; FEMALE; HAZARD RATIO; HUMAN; KIDNEY PELVIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEPHROURETERECTOMY; PREDICTIVE VALUE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TUMOR LOCALIZATION; UPPER TRACT UROTHELIAL CARCINOMA; URETEROSCOPY; UROGENITAL TRACT CANCER;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CARCINOMA, TRANSITIONAL CELL; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUSCLES; NEOPLASM INVASIVENESS; URETERAL NEOPLASMS; URETEROSCOPY; UROTHELIUM;

EID: 84859530619     PISSN: 08927790     EISSN: 1557900X     Source Type: Journal    
DOI: 10.1089/end.2011.0426     Document Type: Article

References (20)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin 2009;59:225-249.
2. Margulis V, Shariat SF, Matin SF, et al. Outcomes of radical nephroureterectomy: A series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer 2009;115:1224-1233.
3. Hall MC, Womack S, Sagalowsky AI, et al. Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: A 30-year experience in 252 patients. Urology 1998;52:594-601. (Pubitemid 28440164)
4. Chen GL, Bagley DH. Ureteroscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys. J Urol 2000;164:1173-1176.
5. Daneshmand S, Quek ML, Huffmann JL. Endoscopic management of upper urinary tract transitional cell carcinoma: Long-term experience. Cancer 2003;98:55-60. (Pubitemid 36741125)
6. Soderdahl DW, Fabrizio MD, Rahman NU, et al. Endoscopic treatment of upper tract transitional cell carcinoma. Urol Oncol 2005;23:114-122. (Pubitemid 40616302)
7. Sowter SJ, Ilie CP, Efthimiou I, Tolley DA. Endourologic management of patients with upper-tract transitional-cell carcinoma: Long-term follow-up in a single center. J Endourol 2007;21:1005-1009. (Pubitemid 47608942)
8. Elliott DS, Segura JW, Lightner D, et al. Is nephroureterectomy necessary in all cases of upper tract transitional cell carcinoma? Long term results of conservative endourologic management of upper tract transitional cell carcinoma in individuals with a normal contralateral kidney. Urology 2001;58 174-178. (Pubitemid 32728049)
9. Renshaw AA. Comparison of ureteral washing and biopsy specimens in the community setting. Cancer 2006;108:45-48. (Pubitemid 43291243)
10. Keeley FX, Kulp DA, Bibbo M, et al. Diagnostic accuracy of ureteroscopic biopsy in upper tract transitional cell carcinoma. J Urol 1997;157:33-37. (Pubitemid 26414922)
11. Guarnizo E, Pavlovich CP, Seiba M, et al. Ureteroscopic biopsy of upper tract urothelial carcinoma: Improved diagnostic accuracy and histopathological considerations using a multi-biopsy approach. J Urol 2000;163:52-55.
12. Smith AK, Lane BR, Larson BT, et al. Inadequacy of biopsy for diagnosis of upper tract urothelial carcinoma: Implications for conservative management. Urology 2011;78:82-86.
13. Thompson RH, Krambeck AE, Lohse CM, et al. Endoscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys. Urology 2008;71:713-717.
14. Messer J, Shariat SF, Brien JC, et al. Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma. BJU Int 2011;108:701-705.
15. El-Hakim A, Weiss GH, Lee BR, Smith AD. Correlation of ureteroscopic appearance with histologic grade of upper tract transitional cell carcinoma. Urology 2004;63:647-650. (Pubitemid 38479400)
16. Ng CK, Shariat SF, Lucas SM, et al. Does the presence of hydronephrosis on preoperative axial CT imaging predict worse outcomes for patients undergoing nephroureterectomy for upper-tract urothelial carcinoma. Urol Oncol 2011;29:27-32.
17. Matin SF, Kamat AM, Grossman HB. High-frequency endoluminal ultrasonography as an aid to the staging of upper tract urothelial carcinoma: Imaging findings and pathologic correlation. J Ultrasound Med 2010;29:1277-1284.
18. Williams SK, Denton KJ, Minervini A, et al. Correlation of upper-tract cytology, retrograde pyelography, ureteroscopic appearance, and ureteroscopic biopsy with histologic examination of upper-tract transitional cell carcinoma. J Endourol 2008;22:71-76.
19. Brien JC, Shariat SF, Herman MP, et al. Preoperative hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial carcinoma. J Urol 2010;184:69-73.
20. Favaretto RL, Shariat SF, Savage C, et al. Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle-invasive and non-organ confined disease in patients with upper tract urothelial carcinoma. BJU Int 2011. E-pub ahead of print.